Protective immunity following immunisation of pigs with aerosol of Actinobacillus pleuropneumoniae serotype 2
- PMID: 8284489
- DOI: 10.1016/0034-5288(93)90095-w
Protective immunity following immunisation of pigs with aerosol of Actinobacillus pleuropneumoniae serotype 2
Abstract
To introduce antigen to the respiratory mucosa, killed Actinobacillus pleuropneumoniae with quil A as adjuvant was administered to pigs as an aerosol. Immunisation by this aerosol induced a marked IgA response in the bronchoalveolar and nasal fluids, and in the serum. Following challenge with live bacteria two weeks after the last exposure to the aerosol, the immunised pigs were protected from the severe pleuropneumonia which developed in non-immunised pigs. The immunised pigs had lower antibody titres in the mucosal fluids and serum after exposure to the challenge. The immune response after experimental infection of non-immunised animals was a weak IgA antibody response in the bronchoalveolar and nasal fluids, whereas the systemic immune response after challenge included both IgA and IgG antibodies.
Similar articles
-
Aerosol exposure of pigs to viable or inactivated Actinobacillus pleuropneumoniae serotype 9 induces antibodies in bronchoalveolar lining fluids and serum, and protects against homologous challenge.Vet Microbiol. 1995 Nov;47(1-2):27-41. doi: 10.1016/0378-1135(95)00106-k. Vet Microbiol. 1995. PMID: 8604553
-
Aerosol treatment of pigs with Actinobacillus pleuropneumoniae serotype 2: mucosal immunity and resistance against challenge.Adv Exp Med Biol. 1995;371B:1611-4. Adv Exp Med Biol. 1995. PMID: 7502867 No abstract available.
-
Oral immunization with lung-pathogenic bacteria is protective against defined challenge in a pig aerosol infection model.Adv Exp Med Biol. 1995;371B:803-6. Adv Exp Med Biol. 1995. PMID: 7502901 No abstract available.
-
Actinobacillus pleuropneumoniae surface polysaccharides: their role in diagnosis and immunogenicity.Anim Health Res Rev. 2000 Dec;1(2):73-93. doi: 10.1017/s1466252300000074. Anim Health Res Rev. 2000. PMID: 11708600 Review.
-
New trends in innovative vaccine development against Actinobacillus pleuropneumoniae.Vet Microbiol. 2018 Apr;217:66-75. doi: 10.1016/j.vetmic.2018.02.028. Epub 2018 Mar 6. Vet Microbiol. 2018. PMID: 29615259 Review.
Cited by
-
Immunization of pigs with Actinobacillus pleuropneumonia live attenuated (gene-deleted) vaccine HB04M intramuscularly or intranasally exhibits remarkably rapid protection against heterologous strain challenge.BMC Vet Res. 2025 Jul 8;21(1):450. doi: 10.1186/s12917-025-04895-6. BMC Vet Res. 2025. PMID: 40629392 Free PMC article.
-
Field experience with two different vaccination strategies aiming to control infections with Actinobacillus pleuropneumoniae in a fattening pig herd.Acta Vet Scand. 2010 Mar 25;52(1):23. doi: 10.1186/1751-0147-52-23. Acta Vet Scand. 2010. PMID: 20334700 Free PMC article.
-
Porcine Reproductive and Respiratory Syndrome Virus: Challenges and Advances in Vaccine Development.Vaccines (Basel). 2025 Feb 28;13(3):260. doi: 10.3390/vaccines13030260. Vaccines (Basel). 2025. PMID: 40266104 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous